Introduction
============

Age-related macular degeneration (AMD), a leading cause of blindness among older individuals in developed countries \[[@r1]\], is a heterogeneous group of disorders with variable clinical findings \[[@r2]\]. It manifests at an early stage with large drusen and pigmentary abnormalities in the retinal pigment epithelium at the macula. With progression to an advanced stage, it presents with geographic atrophy (dry AMD) or exudative maculopathy (wet/neovascular AMD) as the sequela of choroidal neovascularization (CNV).

Inner choroidal vascular networks ending in polypoidal lesions are the defining feature of polypoidal choroidal vasculopathy (PCV) \[[@r3]-[@r5]\], which is now clinically classified into a specific type of AMD \[[@r6]\]. Some clinical and pathological features such as demography \[[@r7]\], pathology \[[@r8]-[@r10]\], and manifestation \[[@r7]\] are common between neovascular AMD and PCV; however, important differences are also noted in clinical behavior \[[@r3]\], histopathology \[[@r11],[@r12]\], and response to therapy \[[@r13],[@r14]\]. These commonalities and differences have been a source of much debate as to whether PCV has a common etiology with neovascular AMD or a distinct phenotype reflecting a different etiology \[[@r8]-[@r12],[@r15]\]. PCV has a particularly high incidence in Asian populations, accounting for 54.7% of patients with findings suggestive of neovascular AMD in the Japanese population \[[@r7]\] and 24.5% in the Chinese population \[[@r16]\], in contrast to only 8 to 13% in European populations \[[@r3]\]. The phenotypic spectrum of AMD is quite heterogeneous among different ethnicities. Dry AMD is more frequent in European populations than in Asians; the reverse is true for neovascular AMD \[[@r17]-[@r19]\].

To date, many studies have reported various gene variants associated with AMD \[[@r20],[@r21]\]. However, findings from most studies have been largely inconclusive because of a lack of consistent replication \[[@r20],[@r21]\]. Thus far, variants in two genomic regions have been consistently reproducible across multiple ethnic groups, including the complement factor H (*CFH*) gene at chromosome 1q32 \[[@r22]-[@r26]\] and the *ARMS2* (*LOC387715*)/*HTRA1* locus at 10q26 \[[@r27]-[@r30]\]. These two loci are associated with all phenotypes of AMD, including early AMD, dry AMD, and neovascular AMD \[[@r25],[@r27]\]. Genetic susceptibility to PCV is also strongly associated with the *CFH* gene and the *ARMS2*/*HTRA1* locus \[[@r31],[@r32]\], thus indicating that these two loci play a general role in the etiology of variable phenotypes of AMD and PCV. Besides these shared genetic associations, two phenotype-specific associations have been found. These associations are common variants in the elastin gene for PCV \[[@r33]\] and an allelic variant (Leu412Phe) in the toll-like receptor 3 (*TLR3*) gene for dry AMD \[[@r34]\]. From the genetic perspective, both general and phenotype-specific pathways may be implicated in the pathophysiology of AMD and PCV. Therefore, to avoid variable findings across studies, attention to disease classification is a key aspect of genetic studies on AMD, as suggested previously \[[@r35]\].

Lin et al. \[[@r36]\] recently reported a previously unknown association between neovascular AMD and the coding Met72Thr (rs1136287) variant in the pigment epithelium-derived factor (*PEDF*) gene in a Taiwan Chinese population. The authors reported that the minor allele T of rs1136287 was significantly associated with increased disease risk, with an odds ratio (OR) of 3.9 under a recessive disease model \[[@r36]\]. At present, there is no evidence for functional relevance of the Met72Thr variant, nor has any biologic explanation been proposed for this association. Still, there are multiple lines of evidence for the importance of the protein product *PEDF* in the pathogenesis of AMD \[[@r37]\], and thus, *PEDF* is a reasonable candidate gene for the disease.

Mattes et al. \[[@r38]\] subsequently failed to replicate this association in a white European population with neovascular AMD. We noted an important difference in the sample ascertainment scheme between these two studies \[[@r36],[@r38]\]. Lin et al. \[[@r36]\] applied consensus criteria for AMD classification derived from analysis of a white population and did not consider findings of indocyanine green (ICG) angiography for disease classification. ICG angiography is the only way to obtain a clear image of PCV lesions \[[@r3]\]. The work of Lin et al. suggests that their cohort might include a considerable amount of PCV, given its high prevalence in the Chinese population \[[@r16]\]. However, Mattes et al. \[[@r38]\] performed ICG angiography and excluded individuals with PCV from case participants. Since genetic susceptibility to distinct AMD phenotypes seems to be influenced by different genetic factors \[[@r33]-[@r35]\], genetic association studies on AMD can be confounded by underlying sample heterogeneity. An example of this situation can be seen in previous studies on *TLR3* for its association with AMD. Edwards et al. \[[@r39]\] examined polymorphisms across *TLR* genes, including the *TLR3* Leu412Phe variant, in a mixed sample of early AMD, dry AMD, and neovascular AMD. This analysis was not restricted to dry AMD, and the authors failed to detect a phenotype-specific association of *TLR3* Leu412Phe with dry AMD. In contrast, Yang et al. \[[@r34]\] selectively studied subgroups of subjects with early AMD, dry AMD, and neovascular AMD and eventually found that the Leu412Phe variant specifically contributes to the risk of developing dry AMD. Similarly, the inconsistent finding of the *PEDF* Met72Thr variant could be due to potential sample heterogeneity between the studies by Lin et al. and Mattes et al. Therefore, this association needed to be examined in a case series of clearly defined individuals with neovascular AMD and PCV. The aim of this study was to validate the previously reported association of the *PEDF* Met72Thr variant in a well characterized Japanese population with neovascular AMD and PCV.

Methods
=======

Study participants
------------------

This study was approved by the Institutional Review Board at Kobe University Graduate School of Medicine and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants. All case and control participants enrolled in this study (more information about participants in [Table 1](#t1){ref-type="table"}) were Japanese individuals recruited from the Department of Ophthalmology at Kobe University Hospital in Kobe, Japan. This is largely the same sample set used in our previous studies in which phenotyping criteria were fully described \[[@r31]-[@r33],[@r40]\]. In brief, all our neovascular AMD and PCV subjects underwent comprehensive ophthalmic examinations, including ICG angiography, and were defined as individuals with angiographically well delineated lesions of CNV or PCV. Patients with secondary choroidal neovascular diseases such as degenerative myopia, idiopathic CNV, ocular trauma, angioid streaks, and presumed ocular histoplasmosis were excluded from the recruitment. The control participants, who were not related to the case participants, were defined as individuals without macular degeneration and changes such as drusen or pigment abnormalities, and thus, were categorized as having the clinical age-related maculopathy staging system stage 1 \[[@r41]\].

###### Characteristics of the study population

                           **Neovascular AMD**   **PCV**   **Controls**
  ------------------------ --------------------- --------- --------------
  Number of participants   116                   140       189
  Males (%)                78                    77        60
  Mean age±SD (years)      75±7.2                73±6.9    72±5.8
  Age range (years)        57--91                57--86    56--95

A total of 116 patients with neovascular AMD, 140 patients with PCV, and 189 control participants were enrolled in the present study. The gender breakdown, mean age, and age range of each population are shown. Abbreviations: age-related macular degeneration (AMD); polypoidal choroidal vasculopathy (PCV); standard deviation (SD).

Genotyping
----------

Genomic DNA was extracted from peripheral blood immediately after it was drawn. We genotyped the Met72Thr variant ([rs1136287](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287)) using TaqMan^®^ SNP Genotyping Assays (Assay ID: C\_\_\_1841779_20; Applied Biosystems, Foster City, CA) on a StepOnePlus™ Real-Time PCR system (Applied Biosystems), in accordance with the manufacturer's instructions. For verification, a random 10% of samples were genotyped twice, yielding 100% concordance.

Statistical analysis
--------------------

Testing for association was performed using software packages [SNPGWA](http://www.phs.wfubmc.edu/public/bios/gene/downloads.cfm) v3.02. Deviations from Hardy--Weinberg equilibrium (HWE) were evaluated using the exact test \[[@r42]\] implemented in [SNPGWA](http://www.phs.wfubmc.edu/public/bios/gene/downloads.cfm). We performed association analyses using the Cochran-Armitage trend test \[[@r43]\] and genotypic (2 degrees of freedom, χ^2^ test), dominant (1 degree of freedom, χ^2^ test), and recessive (1 degree of freedom, χ^2^ test) genetic models. The max(T) permutation procedure implemented in [PLINK](http://pngu.mgh.harvard.edu/purcell/plink/) v1.00 was used with 10,000 iterations to obtain empirical p values \[[@r44]\]. To adjust for age and gender differences between case and control subjects, we conducted logistic regression analyses using JMP version 6.0.3 software (SAS Institute, Cary, NC), assuming a multiplicative codominant genetic model by fitting the number of minor allele carried as an ordinal covariate and age and gender as continuous and categorical covariates, respectively. Power calculations were performed using [QUANTO](http://hydra.usc.edu/gxe) version 1.2 \[[@r45]\]. We had full power to detect the OR reported in the original studies for rs1136287 (OR=3.90 under a recessive genetic model) at p\<0.05 for both neovascular AMD and PCV. Assuming an additive genetic model, we had 80% power to detect an association of this variant with ORs ≥1.61 (or ≤0.62) for the neovascular AMD sample and ≥1.56 (or ≤0.63) for the PCV sample.

Linkage disequilibrium (LD) structures across the *PEDF* gene were compared between Chinese and Japanese populations, using genotype data retrieved from the HapMap \[[@r46]\] CHB (Han Chinese in Beijing, China) and JPT (Japanese in Tokyo, Japan) data sets. These retrieved data were loaded into Haploview \[[@r47]\] to estimate LD parameters and identify haplotype blocks.

Hidden population stratification in genetic association studies can generate a spurious positive or negative association \[[@r48]\]. To prevent potential stratification in our study cohort, we evaluated population stratification using STRUCTURE software \[[@r49]\], as described in previous studies \[[@r40],[@r50],[@r51]\]. The following 38 single nucleotide polymorphisms (SNPs), which were randomly distributed along the genome and are not in LD with each other (r^2^\<0.04), were used for stratification analysis: [rs3818729](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3818729) (1p13.2), [rs696619](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=696619) (1p21.3), [rs9434](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=9434) (1p36.12), [rs1554286](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1554286) (1q32.1), [rs13388696](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=13388696) (2p23.1), [rs1042034](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1042034) (2p24.1), [rs10932613](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10932613) (2q35), [rs7641926](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7641926) (3p26.2), [rs2305619](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2305619) (3q25.32), [rs4074](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4074) (4q13.3), [rs6876885](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6876885) (5p15.1), [rs6459193](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6459193) (6p11.2), [rs3779109](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3779109) (7p22.1), [rs2227667](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2227667) (7q22.1), [rs6468284](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6468284) (8p12), [rs10757278](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=10757278) (9p21.3), [rs955220](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=955220) (9p24.3), [rs1927911](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1927911) (9q33.1), [rs4838590](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4838590) (10q11.22), [rs12806](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=12806) (10q24.2), [rs2019938](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2019938) (11p15.5), [rs609017](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=609017) (11q24.3), [rs3912640](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3912640) (12p13.2), [rs2283299](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2283299) (12p13.33), [rs715948](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=715948) (12q13.3), [rs7328193](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7328193) (13q12.11), [rs1048990](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1048990) (14q13.2), [rs911669](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=911669) (14q32.13), [rs16948719](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16948719) (15q22.31), [rs11076720](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=11076720) (16q24.3), [rs1051009](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1051009) (17p13.2), [rs1292033](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1292033) (17q23.1), [rs7239116](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=7239116) (18q11.2), [rs892115](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=892115) (19p13.2), [rs3826945](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3826945) (19p13.3), [rs844906](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=844906) (20p11.21), [rs2825761](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2825761) (21q21.1), and [rs3884935](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3884935) (22q13.1). The log likelihood of each analysis at a varying number *K* (the number of populations) was computed from three independent runs (20,000 burn-in and 30,000 iterations). The best estimate of *K* was defined by calculating posterior probabilities *Pr* (*K*=1, 2, 3, 4, or 5) based on the log likelihood, as described by Pritchard et al. \[[@r52]\].

Results
=======

A total of 116 patients with neovascular AMD, 140 patients with PCV, and 189 control participants participated in the study. [Table 1](#t1){ref-type="table"} shows the demographic details of the study population. The *PEDF* Met72Thr ([rs1136287](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287)) variant showed no significant deviation from Hardy--Weinberg equilibrium in the control participants (p=0.66).

Details of allele and genotype counts and summary statistics for [rs1136287](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287) are shown in [Table 2](#t2){ref-type="table"}. We found no statistically significant evidence for association between [rs1136287](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287) and either neovascular AMD or PCV under any genetic models ([Table 2](#t2){ref-type="table"}). Adjusting for age and gender by logistic regression analyses did not affect the conclusion (age- and sex-adjusted p=0.59 for neovascular AMD; age- and sex-adjusted p=0.33 for PCV, under a multiplicative codominant model).

###### Allele and genotype distributions of rs1136287 and the results of association tests

  **Status**        **Genotype**   **Allele**   **OR trend\*** **(95% CI)**   **p values (empirical p values)**                                                                 
  ----------------- -------------- ------------ ----------------------------- ----------------------------------- ------------------- ------------- ------------- ------------- -------------
  Control           56 (0.30)      91 (0.48)    42 (0.22)                     175 (0.46)                          \-                  \-            \-            \-            
  Neovascular AMD   41 (0.35)      52 (0.45)    23 (0.20)                     98 (0.42)                           0.86 (0.62--1.18)   0.34 (0.35)   0.58 (0.58)   0.30 (0.32)   0.62 (0.67)
  PCV               32 (0.23)      78 (0.56)    30 (0.21)                     138 (0.49)                          1.13 (0.83--1.55)   0.44 (0.47)   0.32 (0.31)   0.17 (0.20)   0.86 (0.89)

The trend p values were obtained by the Cochran-Armitage trend test. Genotypic p values were generated by chi-square tests on 2×3 contingency tables. Tests for the dominant and recessive models were set up as 2×2 contingency table chi-square tests. The dominant model compared a combination of C/T+T/T genotypes to the homozygous C/C. The recessive model compared a combination of C/C+C/T to the homozygous T/T. Empirical p values were generated by 10,000 permutation tests, using the max(T) permutation procedure implemented in PLINK \[[@r44]\]. Asterisk (\*) indicates OR trend test. Abbreviations: odds ratio (OR); confidence interval (CI); age-related macular degeneration (AMD); polypoidal choroidal vasculopathy (PCV).

We also explored the possibility that failure to replicate the previously reported association could arise due to differences in LD structure between Chinese and Japanese populations---i.e., if the Met72Thr variant is only a proxy for some other true causative variant, the inconsistency may be due to a difference in LD for a pair of the Met72Thr and causal variants between Chinese and Japanese populations. To this end, we compared LD structures across the *PEDF* gene between Chinese and Japanese populations, using genotype data retrieved from the HapMap \[[@r46]\] CHB and JPT data set. This analysis revealed that the HapMap Chinese (CHB) and Japanese (JPT) populations are highly similar with regard to LD pattern and structure of LD blocks across the *PEDF* gene ([Figure 1](#f1){ref-type="fig"}).

![Linkage disequilibrium structure across the pigment epithelium-derived factor gene in Chinese and Japanese populations. Genotype data were retrieved from HapMap CHB (Han Chinese in Beijing, China; **A**) and JPT (Japanese in Tokyo, Japan; **B**) data sets, and linkage disequilibrium (LD) patterns were assessed using Haploview software \[[@r47]\]. Haplotype blocks were determined using the "four-gamete rule" option in this software. Each box provides estimated statistics of the coefficient of determination (r^2^), with darker shades representing stronger LD.](mv-v15-1107-f1){#f1}

Next, we examined SNPs within *PEDF* in an available data set, the [NEI/NCBI dbGAP](http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000001) database. This database provides results of genome-wide association analysis for 395 individuals with AMD and 198 controls from the National Eye Institute Age-Related Eye Disease Study (AREDS). This genome-wide association study investigated seven *PEDF* SNPs, including the SNP [rs1136287](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1136287) (Met72Thr) tested here and six other SNPs ([rs8074840](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=8074840), [rs4274474](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=4274474), [rs2269344](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2269344), [rs3891224](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3891224), [rs2071021](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071021), and [rs6828](http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6828)). None of these seven SNPs showed significant association with AMD in this analysis (p\>0.05).

Hidden population stratification between case and control subjects can be a confounding factor yielding false-positive or false-negative findings \[[@r48]\]. Population stratification was examined by STRUCTURE \[[@r49]\], using 38 unlinked genome-wide SNPs. We found no evidence of stratification in our study cohort, using the formula;
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thus indicating that our results did not arise from population stratification.

Discussion
==========

To validate the recently reported association between the *PEDF* Met72Thr variant and wet AMD in a Taiwan Chinese population \[[@r36]\], we analyzed this variant in Japanese subjects with neovascular AMD and PCV separately, given the possibility that a case population of the original report might be a mixed sample of neovascular AMD and PCV. Despite sufficient power to replicate the originally reported association, we found no statistically significant evidence for association between this variant and either neovascular AMD or PCV.

PEDF is mainly a secreted 50 kDa glycoprotein that is found in various ocular tissues including retinal pigment epithelium and choroid \[[@r53],[@r54]\]. PEDF potently inhibits angiogenesis and plays a pivotal role in maintaining vascular quiescence in the eye \[[@r54],[@r55]\]. Specifically, PEDF has been repeatedly implicated in the pathology of neovascular AMD: CNV is associated with decreased levels of PEDF in an eye with neovascular AMD \[[@r56],[@r57]\], *PEDF* gene transfer in the eye inhibits laser-induced CNV growth and promotes regression of established CNV in a murine model \[[@r58],[@r59]\], and adenoviral vector-mediated intravitreal gene transfer of PEDF seems to help prevent the growth of CNV in patients with neovascular AMD \[[@r60]\]. Thus, from a functional perspective, *PEDF* appeared to be a reasonable candidate for genetic susceptibility to neovascular AMD.

Disease heterogeneity can result in false-positive reporting or can obscure the existence of true associations. Population stratification can also generate inconsistent findings across studies, thus yielding false-positive or false-negative association. To address these concerns, we performed association analysis for both neovascular AMD and PCV because of the unclear definition of the disease phenotype included in the original study \[[@r36]\]. We also examined population stratification in our study cohort and confirmed the lack of stratification. Many other reasons for irreproducibility of initial positive findings have been cited, with failure to exclude chance being considered the most likely explanation for difficulty in replication \[[@r61],[@r62]\]. To protect against a range of confounding factors and to provide greater support for a claim of association, initial positive studies should preferably include multiple replication samples \[[@r61],[@r62]\]. However, Lin et al. did not validate their finding in a second sample, nor did they evaluate potential stratification in their study cohort \[[@r36]\]. Finally, our inability to replicate the previously reported association may result from differences in the structure of LD across the *PEDF* gene region between Chinese and Japanese populations. However, examination of HapMap data \[[@r46]\] revealed that the HapMap Chinese and Japanese populations are similar in LD pattern and structure of LD blocks across the *PEDF* gene ([Figure 1](#f1){ref-type="fig"}). Mattes et al. also \[[@r38]\] failed to replicate the original finding of Lin et al. \[[@r36]\]. Additional support of our negative findings comes from the genome-wide association study on the [AREDS cohort](http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000001). Our experience highlights the importance of replication efforts in genetic association studies of complex human diseases.

In conclusion, we report a lack of association between the *PEDF* Met72Thr variant and either neovascular AMD or PCV in a Japanese population. We conclude that the Met72Thr variant does not play a significant role in the risk of developing neovascular AMD or PCV.
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